Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Non-Current Assets (2023 - 2025)

Historic Non-Current Assets for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $2.2 million.

  • Upstream Bio's Non-Current Assets fell 5986.73% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2024, which is 116683.17% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Non-Current Assets is $2.2 million, which was down 5986.73% from $2.2 million recorded in Q2 2025.
  • Upstream Bio's 5-year Non-Current Assets high stood at $5.4 million for Q3 2024, and its period low was $202000.0 during Q4 2023.
  • Moreover, its 3-year median value for Non-Current Assets was $2.3 million (2025), whereas its average is $2.5 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first soared by 116683.17% in 2024, then plummeted by 5986.73% in 2025.
  • Quarter analysis of 3 years shows Upstream Bio's Non-Current Assets stood at $202000.0 in 2023, then surged by 1166.83% to $2.6 million in 2024, then decreased by 14.89% to $2.2 million in 2025.
  • Its Non-Current Assets was $2.2 million in Q3 2025, compared to $2.2 million in Q2 2025 and $2.4 million in Q1 2025.